| Date | Title | Description | Source |
| 25.04.2024 | 1st Quarter Results | 1st Quarter Results
Thu, Apr 25, 2024 08:00 CET Report this content
AstraZeneca
25 April 2024
Q1 202... | news.cisio... |
| 26.12.2023 | AstraZeneca to acquire Gracell, furthering cell therapy ambi... | - | vivocapita... |
| 06.09.2023 | Gracell Biotechnologies to Present Updated Clinical Data on ... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Sept. 6, 2023 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 07.08.2023 | Gracell Biotechnologies Announces Up to $150 Million Private... | - | tcgcrossov... |
| 07.08.2023 | Gracell Biotechnologies Announces Up to $150 Million Private... | Oversubscribed transaction led by Vivo Capital and joined by leading healthcare investors including ... | en.prnasia... |
| 04.06.2023 | Gracell Biotechnologies Presents Updated Data of Deep and Du... | Data on BCMA/CD19 dual-targeting FasTCAR-T GC012F showed 100% minimal residual disease (MRD) negativ... | en.prnasia... |
| 15.05.2023 | Gracell Biotechnologies Initiates Investigational Study Eval... | Gracell announces start of investigator-initiated trial to expand clinical evaluation of FasTCAR-T G... | en.prnasia... |
| 12.05.2023 | Gracell Biotechnologies to Present Clinical Data on BCMA/CD1... | First disclosure of data from Phase 1 study of the donor-derived allogeneic CAR-T GC007g shows 100% ... | en.prnasia... |
| 26.04.2023 | Gracell Biotechnologies to Present Updated Clinical Data on ... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, April 26, 2023 /PRNewswire/ -- Gracell Biotechnol... | en.prnasia... |
| 28.02.2023 | Gracell Biotechnologies to Participate in Oppenheimer 33rd A... | SAN DIEGO Calif., and SUZHOU and SHANGHAI, China, Feb. 28, 2023 /PRNewswire/ -- Gracell Biotechnolog... | en.prnasia... |
| 27.02.2023 | Gracell Biotechnologies to Report Fourth Quarter 2022 Financ... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Feb. 27, 2023 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 13.02.2023 | Gracell Biotechnologies Announces China NMPA Clearance for I... | Approval follows U.S. FDA clearance of IND application for BCMA/CD19 dual-targeting FasTCAR-T GC012F... | en.prnasia... |
| 03.02.2023 | Gracell Biotechnologies Announces FDA Clearance of the IND A... | BCMA/CD19 dual-targeting FasTCAR-T GC012F has demonstrated deep responses and favorable safety profi... | en.prnasia... |
| 11.12.2022 | Gracell Biotechnologies Presents Clinical Data for FasTCAR-T... | BCMA/CD19 dual-targeting FasTCAR-T GC012F data from ongoing clinical trial presented at 64th America... | einpresswi... |
| 11.12.2022 | Gracell Biotechnologies Presents Clinical Data for FasTCAR-T... | BCMA/CD19 dual-targeting FasTCAR-T GC012F data from ongoing clinical trial presented at 64th America... | en.prnasia... |
| 23.11.2022 | Gracell Biotechnologies to Participate in Two Upcoming Inves... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Nov. 23, 2022 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 16.11.2022 | Gracell Biotechnologies Wins 2022 Fierce Life Sciences Innov... | FasTCAR next-day manufacturing autologous CAR-T platform recognized with prestigious biotech innovat... | en.prnasia... |
| 03.11.2022 | Gracell Biotechnologies to Present First Clinical Data of Fa... | BCMA/CD19 dual-targeting FasTCAR-T GC012F demonstrated 100% ORR and 100% MRD negativity in the 13 pa... | en.prnasia... |
| 31.10.2022 | Gracell Biotechnologies to Report Third Quarter 2022 Financi... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Oct. 31, 2022 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 24.10.2022 | Gracell Biotechnologies to Participate in Two Upcoming Inves... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Oct. 24, 2022 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 17.10.2022 | Gracell Biotechnologies Doses First Patient in Phase 2 Porti... | Clinical trial assessing allogeneic, HLA-matched, donor-derived allogeneic CAR-T therapy
SAN DIEGO, ... | en.prnasia... |
| 14.09.2022 | Gracell Biotechnologies to Participate in Three Upcoming Inv... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Sept. 14, 2022 /PRNewswire/ -- Gracell Biotechnol... | en.prnasia... |
| 29.08.2022 | Gracell Biotechnologies to Participate in Four Upcoming Inve... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Aug. 29, 2022 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 02.08.2022 | Gracell Biotechnologies to Report Second Quarter 2022 Financ... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Aug. 2, 2022 /PRNewswire/ -- Gracell Biotechnolog... | en.prnasia... |
| 01.08.2022 | Gracell Biotechnologies Appoints Accomplished Clinical Leade... | Dr. Li brings deep oncology clinical development, medical affairs and U.S. regulatory experience
SAN... | en.prnasia... |
| 26.07.2022 | Gracell Biotechnologies to Participate in BTIG 2022 Biotechn... | SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, July 26, 2022 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 19.07.2022 | Gracell Biotechnologies Appoints Veteran BioPharma Executive... | SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, July 19, 2022 /PRNewswire/ -- Gracell Biotechnolog... | en.prnasia... |
| 14.06.2022 | Gracell Biotechnologies to Participate in Three Upcoming Inv... | SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, June. 14, 2022 /PRNewswire/ -- Gracell Biotechnologie... | en.prnasia... |
| 03.06.2022 | Gracell Biotechnologies Schedules Clinical Update Call After... | SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, June. 3, 2022 /PRNewswire/ -- Gracell Biotechnolog... | en.prnasia... |
| 19.05.2022 | Gracell Biotechnologies to Participate in Three Upcoming Inv... | SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, May 19, 2022 /PRNewswire/ -- Gracell Biotechnologies ... | en.prnasia... |
| 12.05.2022 | Gracell Biotechnologies to Present Clinical Data on BCMA/CD1... | SAN DIEGO, Calif., SUZHOU and SHANGHAI, China , May 12, 2022 /PRNewswire/ -- Gracell Biotechnologies... | en.prnasia... |
| 28.04.2022 | Gracell Biotechnologies Announces Details of Oral Abstract P... | Gracell to present longer-term follow-up clinical data evaluating GC012F, an autologous CAR-T therap... | en.prnasia... |
| 14.04.2022 | Gracell Biotechnologies' Abstract on GC012F, a BCMA/CD19 Dua... | PALO ALTO, Calif. and SUZHOU, China, April 14, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (&q... | en.prnasia... |
| 09.04.2022 | Gracell Biotechnologies to Present Data at AACR Annual Meeti... | Allogeneic, off-the-shelf CAR-T therapy with CD19/CD7 dual-directed CAR shows promising early result... | en.prnasia... |
| 09.03.2022 | Gracell Biotechnologies Announces Details of Poster Presenta... | Gracell to present first-in-human data on GC502, an allogeneic CD19/CD7 dual-directed chimeric antig... | en.prnasia... |
| 22.02.2022 | Gracell Biotechnologies Announces Multiple Advancements of T... | SUZHOU, China, and PALO ALTO, Calif., Feb. 22, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (&q... | en.prnasia... |
| 17.02.2022 | Gracell Biotechnologies Doses First Patients in First-in-Hum... | SUZHOU, China and PALO ALTO, Calif., Feb. 17, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (&qu... | en.prnasia... |
| 12.01.2022 | Gracell Biotechnologies Unveils Innovation Center in U.S. | SUZHOU, China and PALO ALTO, Calif., Jan. 12, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NAS... | en.prnasia... |
| 16.12.2021 | Gracell Biotechnologies Selected for Addition to NASDAQ Biot... | SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Dec. 16, 2021 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 23.11.2021 | Gracell Biotechnologies Announces Senior Management Team Sha... | SUZHOU, China and PALO ALTO, Calif., Nov. 23, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NAS... | en.prnasia... |
| 19.11.2021 | Gracell Biotechnologies Granted FDA Orphan Drug Designation ... | SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Nov. 19, 2021 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 15.11.2021 | Gracell Biotechnologies Reports Third Quarter 2021 Unaudited... | SUZHOU, China and PALO ALTO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ... | marketscre... |
| 04.11.2021 | Gracell Biotechnologies to Present Preclinical Results of Tr... | SUZHOU and SHANGHAI, China, and PALO ALTO, California, Nov. 4, 2021 /PRNewswire/ -- Gracell Biotechn... | en.prnasia... |
| 16.08.2021 | Gracell Biotechnologies Signs Exclusive License Agreement wi... | SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Aug. 16, 2021 /PRNewswire/ -- Gracell Biotechnolo... | en.prnasia... |
| 26.05.2021 | Gracell Biotechnologies Hosting Key Opinion Leader Webinar o... | SUZHOU, China and PALO ALTO, Calif., May 26, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASD... | en.prnasia... |
| 20.05.2021 | Gracell Biotechnologies to Present Updated Results of GC012F... | SUZHOU, China and PALO ALTO, Calif., May 20, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASD... | en.prnasia... |
| 17.05.2021 | GRACELL BIOTECHNOLOGIES INC.
Gracell Biotechnologies : Repo... | Reported updated long-term follow-up data for TruUCAR-enabled CD7-targeted CAR-T product candidate G... | marketscre... |
| 11.05.2021 | Gracell Biotechnologies Appoints Seasoned Gene & Cell Th... | SUZHOU, China and PALO ALTO, California, China, May 11, 2021 /PRNewswire/ -- Gracell Biotechnologies... | en.prnasia... |
| 31.03.2021 | GRACELL BIOTECHNOLOGIES INC.
Gracell Biotechnologies : Anno... | SUZHOU and SHANGHAI, China, March 31, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRC... | marketscre... |
| 05.12.2020 | Gracell Biotechnologies Announces Presentation of First-in-H... | | prnewswire... |
| 04.11.2020 | Gracell Biotechnologies Announces Two Oral Presentations at ... | | prnewswire... |
| 29.10.2020 | Chinese biotech firm Gracell nets $100m from Wellington, Orb... | Chinese clinical-stage biopharmaceutical firm Gracell Biotechnologies Inc. has completed a $100 mill... | dealstreet... |
| 29.10.2020 | Gracell Biotechnologies Raises $100M in Series C Funding | Gracell Biotechnologies Inc., a Shangai, China-based clinical-stage biopharmaceutical company dedica... | finsmes.co... |
| 28.10.2020 | Gracell Biotechnologies Raises $100 Million in Series C Fund... | | prnewswire... |
| 27.02.2019 | China's Gracell Biotechnology Rakes In USD85 Million in Seri... | (Yicai Global) Feb. 26 -- Emerging cell therapy company Gracell Biotechnology has closed its series ... | yicaigloba... |
| 27.02.2019 | China's Gracell Biotechnology Rakes In USD85 Million in Seri... | (Yicai Global) Feb. 26 -- Emerging cell therapy company Gracell Biotechnology has closed its series ... | yicaigloba... |
| 26.02.2019 | Term Sheet — Tuesday, February 26 | MO’ MONEY, MO’ PROBLEMS
Good morning, Term Sheet readers.
Paid Content Securing the enterprise witho... | fortune.co... |
| 25.02.2019 | Gracell Biotechnologies Completes $85M in Series B Funding | Gracell Biotechnologies, Co., Ltd., a Suzhou, China-based innovative biomedical company, completed a... | finsmes.co... |
